POELLATH advises management of rehaneo GmbH on sale to Fremman Capital

Pan-European investment firm Fremman Capital (“Fremman”) has acquired a majority stake in rehaneo GmbH (“rehaneo”), a leading provider of outpatient rehabilitation, aftercare, prevention and occupational health management in Germany. The seller is European investment company GIMV. Founders Bruno Crone (CEO) and co-founder Christoph Dühr (COO) will remain significantly involved in the company and continue in their existing roles. Together with Fremman, the management team at rehaneo will continue the proven growth strategy, further consolidate the fragmented sector and thus build a leading company in Europe. The transaction closed on January 31. In connection with the sale, POELLATH provided comprehensive legal advice to the management of rehaneo regarding management participation.

Munich-based rehaneo GmbH provides outpatient rehabilitation, rehabilitation aftercare, physiotherapy and occupational therapy, as well as prevention and occupational health management. Since its foundation, rehaneo has integrated 15 companies with a total of 27 locations into the group throughout Germany. The company’s goal is to further consolidate the care network and thus be able to offer even more people professional rehabilitation measures close to home. In addition to the group’s continuous growth and the expansion of its locations, the primary focus is on the quality of its services. rehaneo employs more than 1,300 people who care for over 100,000 patients annually.

POELLATH provided comprehensive legal advice to the management of rehaneo on the management participation in relation to the sale with the following Munich-based team:

• Dr. Benedikt Hohaus (partner, lead, management participation, M&A/PE)
• Dr. Verena Stenzel (associated partner, M&A/PE)